Crinone + Duphaston
ApprovedTerminated 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Infertility
Conditions
Infertility
Trial Timeline
May 31, 2019 → Oct 27, 2021
NCT ID
NCT03858049About Crinone + Duphaston
Crinone + Duphaston is a approved stage product being developed by Merck for Infertility. The current trial status is terminated. This product is registered under clinical trial identifier NCT03858049. Target conditions include Infertility.
What happened to similar drugs?
10 of 20 similar drugs in Infertility were approved
Approved (10) Terminated (3) Active (10)
🔄GenSci094 + Placebo RecFSH / follitropin alfa + Biological: RecFSH / Follitropin alfa (Days 1 to 7) + Placebo GenSci094 + RecFSH / Follitropin alfa (Days 8 to hCG) + Ganirelix + hCG + ProgesteroneSun PharmaceuticalPhase 3
Hype Score Breakdown
Clinical
20
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03858049 | Approved | Terminated |
Competing Products
20 competing products in Infertility